{"title": "DTaP-polio combo vaccine does well in Phase III trials", "author": null, "url": "https://www.contemporarypediatrics.com/view/dtap-polio-combo-vaccine-does-well-phase-iii-trials", "hostname": "contemporarypediatrics.com", "description": "Positive Phase III results from a vaccine that combines four existing immunizations together were reported online by Pediatric Infectious Disease Journal.", "sitename": "Contemporary Pediatrics", "date": "2008-03-27", "cleaned_text": "Positive Phase III results from a vaccine that combines four existing immunizations together were reported online by Pediatric Infectious Disease Journal. Positive Phase III results from a vaccine that combines four existing immunizations together were reported online by Pediatric Infectious Disease Journal. Kinrix is GlaxoSmithKline's name for a combination of inactivated polio and a DTaP (diphtheria, tetanus, and acellular pertussis) vaccinations. The combined product would require one shot, not two. The phase III results showed immune response and safety profile to the individually-administered shots. It enrolled over 4,000 children ages 4 to 6. The most common adverse event was injection site pain (over 50%, followed by redness, swelling, and increase in arm circumference (all "}